1. 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3). (5th December 2016) Authors: Cardoso, F.; Costa, A.; Senkus, E.; Aapro, M.; André, F.; Barrios, C. H.; Bergh, J.; Bhattacharyya, G.; Biganzoli, L.; Cardoso, M. J.; Carey, L.; Corneliussen-James, D.; Curigliano, G.; Dieras, V.; El Saghir, N.; Eniu, A.; Fallowfield, L.; Fenech, D.; Francis, P.; Gelmon, K. Journal: Annals of oncology Issue: Volume 28:Number 1(2017) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). (February 2017) Authors: Cardoso, F.; Costa, A.; Senkus, E.; Aapro, M.; André, F.; Barrios, C.H.; Bergh, J.; Bhattacharyya, G.; Biganzoli, L.; Cardoso, M.J.; Carey, L.; Corneliussen-James, D.; Curigliano, G.; Dieras, V.; El Saghir, N.; Eniu, A.; Fallowfield, L.; Fenech, D.; Francis, P.; Gelmon, K. Journal: Breast Issue: Volume 31(2017) Page Start: 244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). (February 2017) Authors: Cardoso, F.; Costa, A.; Senkus, E.; Aapro, M.; André, F.; Barrios, C.H.; Bergh, J.; Bhattacharyya, G.; Biganzoli, L.; Cardoso, M.J.; Carey, L.; Corneliussen-James, D.; Curigliano, G.; Dieras, V.; El Saghir, N.; Eniu, A.; Fallowfield, L.; Fenech, D.; Francis, P.; Gelmon, K. Journal: Breast Issue: Volume 31(2017) Page Start: 244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Accelerating progress from advanced to early breast Cancer. (April 2021) Authors: Rugo, H. Journal: Breast Issue: Volume 56(2021)Supplement 1 Page Start: S4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1, 000 patients. (October 2020) Authors: Innocenti, F.; Wang, J.; Sibley, A.; Jiang, C.; Etheridge, A.; Shen, F.; Patel, J.; Daniel, H.; Dees, E.; Howard, M.; Bertagnolli, M.; Rugo, H.; Kindler, H.; Kelly, W.; Ratain, M.; Kroetz, D.; Owzar, K.; Schneider, B.; Lin, D.; Quintanilha, J. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244–259]. (April 2017) Authors: Cardoso, F.; Costa, A.; Senkus, E.; Aapro, M.; André, F.; Barrios, C.H.; Bergh, J.; Bhattacharyya, G.; Biganzoli, L.; Cardoso, M.J.; Carey, L.; Corneliussen-James, D.; Curigliano, G.; Dieras, V.; El Saghir, N.; Eniu, A.; Fallowfield, L.; Fenech, D.; Francis, P.; Gelmon, K. Journal: Breast Issue: Volume 32(2017) Page Start: 269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. HERITAGE: a phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus herceptin. (February 2017) Authors: Rugo, H.; Barve, A.; Waller, C.; Bronchud, M.H.; Herson, J.; Yuan, J.; Manikhas, A.; Bondarenko, I.; Mukhametshina, G.; Nemsadze, G.; Parra, J.; Abesamis Tiambeng, M.L.; Baramidze, K.; Akewanlop, C.; Vynnychenko, I.; Sriuranpong, V.; Mamillapalli, G.; Ray, S.; Yanez Ruiz, E.P.; Pennella, E. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Matching adjusted indirect comparison of PFS & OS comparing ribociclib + letrozole vs palbociclib + letrozole as first-line treatment of HR+/HER2− ABC: Analysis based on updated PFS & final OS results of MONALEESA-2 & PALOMA-2. (November 2022) Authors: Jhaveri, K.; O'Shaughnessy, J.; Fasching, P.; Cardoso, F.; Tolaney, S.; Hamilton, E.; Sharma, V.K.; Biswas, C.; Haftchenary, S.; Pathak, P.; Rugo, H. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P017 Abemaciclib + endocrine therapy (ET) for HR+, HER2-, node-positive, high-risk EBC: results from a pre-planned monarchE overall survival (OS) interim analysis (IA), including 4-year efficacy outcomes. (April 2023) Authors: Johnston, S.; Toi, M.; O'Shaughnessy, J.; Rastogi, P.; Campone, M.; Neven, P.; Huang, C.S.; Huober, J.; Jaliffe, G. Garnica; Cicin, I.; Tolaney, S.; Goetz, M.P.; Rugo, H.; Senkus, E.; Testa, L.; Del Mastro, L.; Shimizu, C.; Wei, R.; Shahir, A.; Munoz, M. Journal: Breast Issue: Volume 68(2023) Page Start: S22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P182 NEPA, a new combination antiemetic, exhibits sustained efficacy over repeated chemotherapy cycles. (March 2015) Authors: Aapro, M.; Rugo, H.; Rizzi, G. Journal: Breast Issue: Volume 24(2015)Supplement 1 Page Start: S88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗